Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Aspergillus tracheobronchitis (ATB) is a rare but severe infection in immunocompromised patients that is distinct from invasive pulmonary aspergillosis. A 50-year-old man undergoing dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy for NK/T-cell lymphoma developed febrile neutropenia and worsening respiratory failure. Computed tomography revealed airway epithelial detachment and bronchoscopy confirmed pseudomembrane formation. Due to his "Do Not Intubate" status, mechanical ventilation was not initiated, and he died of CO narcosis. Autopsy histopathologically confirmed pseudomembranous ATB. This case underscores the need for early bronchoscopy in high-risk patients with type 2 respiratory failure that cannot be explained by imaging findings alone, highlighting the crucial need for timely intervention to improve outcomes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2169/internalmedicine.5639-25 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pseudomembranous tracheobronchitis is a relatively rare disease, and it is very easy for clinicians to misdiagnose. It is particularly necessary for the patient presenting with recurrent pyrexia and hemoptysis in the absence of clear-cut pulmonary radiological findings to receive a bronchoscopy.
View Article and Find Full Text PDFAcute Respiratory Distress Syndrome Due to COVID-19-Associated Pulmonary Aspergillosis with Rare Extensive Tracheobronchial Pseudomembranous Involvement: A Case Report.
Mycopathologia
July 2025
PCCM, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China.
COVID-19-associated pulmonary aspergillosis (CAPA) significantly exacerbates the clinical outcomes of COVID-19 patients, contributing to heightened mortality. Aspergillus tracheobronchitis, a manifestation of invasive pulmonary aspergillosis, specifically involves the tracheobronchial tree. According to the 2020 European Confederation of Medical Mycology/International Society for Human and Animal Mycology (ECMM/ISHAM) consensus criteria, airway biopsy via bronchoscopy is the definitive method for CAPA diagnosis, underscoring its critical role in the management of COVID-19 patients.
View Article and Find Full Text PDFA Case of CO Narcosis in a Patient with Histopathological Features Suggestive of Aspergillus Tracheobronchitis During Treatment for Malignant Lymphoma.
Intern Med
July 2025
Department of Respiratory Medicine, Matsuyama Red Cross Hospital, Japan.
Aspergillus tracheobronchitis (ATB) is a rare but severe infection in immunocompromised patients that is distinct from invasive pulmonary aspergillosis. A 50-year-old man undergoing dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy for NK/T-cell lymphoma developed febrile neutropenia and worsening respiratory failure. Computed tomography revealed airway epithelial detachment and bronchoscopy confirmed pseudomembrane formation.
View Article and Find Full Text PDFPaving Stones in the Trachea.
Respirol Case Rep
April 2025
College of Pulmonary & Critical Care Medicine, 8th Medical Centre, Chinese PLA General Hospital Beijing People's Republic of China.
Ulcer and white mucosal protrusion that resembled paving stones in the trachea were revealed under bronchoscopy in our case. Pathology of the mucosa indicated a large number of fungal hyphae. The patient was diagnosed as having invasive aspergillus tracheobronchitis (IATB).
View Article and Find Full Text PDFWhen COPD meets Aspergillus: A treatment Odyssey and critical insights from a 76-year-old female patient's journey: A case report.
Medicine (Baltimore)
April 2025
Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China.
Rationale: Chronic obstructive pulmonary disease (COPD) is a common respiratory disorder characterized by persistent limitation of airflow. Fungal infections are not uncommon in patients with COPD. However, reports on the short-term improvement in lung function in COPD patients with IgE-negative Aspergillus tracheobronchitis (ATB) following antifungal treatment are currently rare.
View Article and Find Full Text PDF